European Mid-Market Debt Update – Spring 2021
Mar 31, 2021

Healthcare Services Sector Update – January 2021
Feb 22, 2021
by Brooks Dexter, Eric Coburn, Priyanka Sharma

As the COVID-19 outbreak continues to evolve, organizations are navigating the various stages of the M&A and transaction lifecycle to maximize their value. Whether acting as a buy- or sell-side participant, Kroll has a proven track record helping clients identify and investigate potential problems and assess the various financial and operational strategies available through every stage of a deal. Our team of experts is ready to assist and provide sound advice on distressed M&A, cash availability analysis, comprehensive due diligence, fairness opinions, disputes and restructuring considerations, among others.
Learn more about our COVID-19 risk management solutions.
Mar 31, 2021
Feb 22, 2021
by Brooks Dexter, Eric Coburn, Priyanka Sharma
Dec 15, 2020
Nov 27, 2020
by Andreas Stoecklin, Philipp Bose, Dafydd Evans, Paul Teuten, Javier Zoido, Jacques Giard, Jochem Quaak, David Althoff, Stephen Burt, Howard Johnson, David Lu, Katsumi Asai
Aug 27, 2020
by Bob Bartell, CFA, Chris Janssen, Stephen Burt, Josh Benn, Jeff Schiedemeyer, Andreas Stoecklin, Brian Cullen, David Lu
Aug 13, 2020
by Howard Johnson, Devin Kennealy
Jul 24, 2020
by Mark Kwilosz, Stephen Burt, David Althoff, Victor Caruso, Howard Johnson, Andreas Stoecklin, Paul Teuten, David Lu, Katsumi Asai
Jul 14, 2020
by James Rebello, Ham Crawford
Kroll’s investment banking practice has extensive experience in M&A deal strategy and structuring, capital raising, transaction advisory services and financial sponsor coverage.
Kroll professionals have advised hundreds of companies, investors and other stakeholders at all stages of distressed transactions and special situations.